Ipca Laboratories stocks: Buy Ipca Laboratories, target price Rs 970: Nagaraj Shetti
Ipca Laboratories, incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 23532.33 Crore) operating in Pharmaceuticals sector.
Stay updated with breaking news from Ipca Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ipca Laboratories, incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 23532.33 Crore) operating in Pharmaceuticals sector.
Lupin Q3 net profit beats expectations, but Street awaits more triggers The move impacts multinational drugmakers, like Abbott Laboratories Ltd and GlaxoSmithKline Plc, and a number of local firms, including Lupin Ltd, Cadila Healthcare Ltd and Ipca Ltd, all of whom sell drugs added to the list. Photo: Bloomberg 1 min read Share Via Read Full Story Lupin's December quarter performance was led by a recovery in US sales growth, though domestic sales also revived after facing covid-19 led disruptions. US, which remains the largest market and drives overall earnings, grew well during the quarter....